MARKET

CMVLF

CMVLF

Cellectis
OTCPK
4.500
NaN%
Closed 09:30 08/21 EDT
OPEN
--
PREV CLOSE
4.500
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
4.500
52 WEEK LOW
2.600
MARKET CAP
327.14M
P/E (TTM)
-6.9231
1D
5D
1M
3M
1Y
5Y
1D
Barclays Sticks to Their Buy Rating for Cellectis SA (CLLS)
TipRanks · 08/07 08:36
Cellectis Advances Allogeneic CAR-T Pipeline as Cash Runway Extends Into Late 2027
TipRanks · 08/06 21:55
Cellectis Updates Share Capital and Voting Rights as of July 31, 2026
TipRanks · 08/05 21:34
Cellectis Sets August 6 Date to Release Q2 2026 Results
TipRanks · 07/30 21:31
Citizens biotech analyst holds an analyst/industry conference call
TipRanks · 07/06 18:35
Citizens biotech analysts hold an analyst/industry conference call
TipRanks · 07/02 19:25
Cellectis wins FDA RMAT status for leukemia CAR-T candidate lasme-cel; shares rise
Seeking Alpha · 06/10 04:12
Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA
TipRanks · 06/09 20:40
More
About CMVLF
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA stock information, including OTCPK: CMVLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMVLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMVLF stock methods without spending real money on the virtual paper trading platform.